DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic TargetsAllison R. Hanaford, Eric H. Raabe, Alykhan F. Shamji et al.|Clinical Cancer Research|2016Cited by 68
STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cellsJong Wook Kim, William C. Hahn|eLife|2020Cited by 60
Supplementary Figure 2 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic TargetsAllison R. Hanaford, Eric H. Raabe, Tenley C. Archer et al.|Unknown|2023Cited by 0
Supplementary Figure 2 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic TargetsAllison R. Hanaford, Eric H. Raabe, Tenley C. Archer et al.|Unknown|2023Cited by 0
Supplementary Figure 3 from DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic TargetsAllison R. Hanaford, Eric H. Raabe, Tenley C. Archer et al.|Unknown|2023Cited by 0